
Drugs IPOs Depend o...


| Price and Volume | |
|---|---|
| Recent Price | 9.09 |
| 52 Week High | 13.56 |
| 52 Week Low | 8.48 |
| Avg. Daily Vol. (Mil) | 3.71 |
| Beta (3 year) | 1.48 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,149.40 |
| Shares Out (Mil) | 236.46 |
| Float (Mil) | 208.13 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.00 |
| Current Ratio | 1.60 |
| LT Debt/ Equity | 0.03 |
| Total Debt / Equity | 0.05 |
| Valuation Ratios | |
| Price Earnings | 13.00 |
| Price/Sales | 0.58 |
| Price/Book | 1.13 |
| Price/Cash Flow | 7.40 |
| Per Share Data | |
| Earnings | 0.70 |
| Sales | 15.74 |
| Book Value | 8.05 |
| Cash Flow | 1.23 |
| Business Summary | |
|---|---|
| McDermott International Inc is an engineering, procurement, construction and Installation Company engaged on designing and executing complex offshore oil and gas projects. | |
| General Information | |
| 757 North Eldridge Parkway
Houston, TX 77079 |
|
| www.mcdermott.com | |
| Industry : Energy | |
| Sector: Basic Materials | |
| Employees: 14000 | |
| CEO: Stephen M. Johnson | |
| Short Interest | |
| Current Month (Mil) | 20.98 |
| Previous Month (Mil) | 22.42 |
| Short Interest Ratio (Days) | 4.00 |
| Management Effectiveness | |
| Return on Equity | 9.30 |
| Return on Assets | 5.50 |
| Return on Investments | 9.00 |
| Profitability | |
| Gross Margin | 16.70 |
| EBIT Margin | 8.20 |
| Profit Margin | 4.70 |